OBA News
Current  Archive    
1 2 3 4 5 6 7
Oregon Biotech and Science Leaders Gather September 28 for "Platforms, Pathways and Pioneers" Conference
Monday, September 19, 2011 (84 reads)


Oregon Bioscience Association News Release

(Portland, Ore.) -- Oregon’s biotechnology and life science leaders are gathering on September 28 for Platforms, Pathways and Pioneers: Oregon’s Bioscience Progress, Oregon Bio’s annual conference, held this year at Portland State University’s newly remodeled, state-of-the art Smith Ballroom.


Read More
    
OSU Posts Record $4M in Tech Transfer Income
Sunday, September 18, 2011 (177 reads)


Date: Friday, September 16, 2011, 6:22am PDT
Erik Siemers Business Journal Staff Writer -
Portland Business Journal

Oregon State University’s efforts to expand its technology transfer operations paid off, with royalties from university-produced research growing 63 percent in the fiscal year to $4 million.

And the Corvallis campus said that figure could rise even higher with the passage of the Leahy-Smith America Invents Act, the patent reform bill expected to be signed Friday by President Barack Obama. The bill is designed to make patent approvals more swift, moving the U.S. from a “first to invent” system to a “first to file” system.



Read More
    
FEI, OHSU Partner to Create a 'Living Lab for Cell Biology'
Thursday, September 15, 2011 (70 reads)


FEI News Release - PORTLAND, Ore., Sept. 13, 2011 (GLOBE NEWSWIRE)

FEI (Nasdaq:FEIC) and Oregon Health & Science University (OHSU) today announced a partnership to create the OHSU/FEI Living Lab for Cell Biology that will provide researchers with several state-of-the-art electron microscopes to advance the understanding and treatment of complex diseases such as cancer and AIDS.


Read More
    
BIO Praises Final Passage of Patent Reform Legislation
Monday, September 12, 2011 (86 reads)


BIO Praises Final Passage of Patent Reform Legislation.pdf

    
HemCon Gains FDA Nod for Surgical Bandage
Tuesday, August 30, 2011 (293 reads)


Portland Business Journal - by Robert Goldfield , special sections editor Date: Wednesday, August 24, 2011, 1:26pm PDT

Recent Food and Drug Administration approval of a surgical bandage gives HemCon Medical Technologies Inc. entry to a market valued at $850 million, the company said Wednesday.


Read More
    

 Underwriting Sponsors
 Sustaining Sponsors